Latest Updates

New Study Will Examine How Robustly Individuals Respond to COVID-19 Vaccination

March 03, 2021
This will be one of the first and largest studies to examine the impact of factors like age and stress on vaccination effectiveness.

COVID-19 Study Finds Increase of Coronavirus Variants in San Francisco’s Mission District 

February 22, 2021
New results from an ongoing collaborative effort to slow the spread of COVID-19 shows that the prevalence of a coronavirus lineage, characterized by the L452R substitution and two other mutations in the virus’s spike protein, has significantly increased in recent months.

Study Estimates Excess Deaths in US from COVID-19 Pandemic Unemployment 

February 18, 2021
UCSF researchers now have an estimate of how many people may have died as a result of pandemic-related unemployment.

UCSF Partnership With San Francisco Brings COVID-19 Vaccinations to the Mission District

February 02, 2021
The vaccination site builds off previous work with Unidos en Salud to bring COVID-19 testing to the Mission District.

UCSF Expands Vaccination Effort in Partnership with City of San Francisco

January 28, 2021
As its supply of COVID-19 vaccines increases, UC San Francisco is expanding its vaccination efforts to those most at risk – the elderly and health care workers in the community

COVID-19 Vaccine Fact Vs. Fiction: An Expert Weighs in on Common Fears

January 27, 2021
We posed the most common COVID-19 vaccine quandaries to Bryn Boslett, MD, an infectious disease expert who is leading the vaccination effort at UCSF. She explains why mRNA vaccines won’t affect your DNA, which allergies pose a risk, what 95 percent efficacy really means, and more.

Cancer Drug Shows Potent Activity in the Lab Against SARS-CoV-2, Including B.1.1.7 Variant

January 25, 2021
In two preclinical models of COVID-19, plitidepsin showed a 100-fold reduction in viral replication in the lungs and demonstrated an ability to reduce lung inflammation.

Severe COVID-19 Disables Disease-Fighting Immune Circuit 

January 25, 2021
Patients with severe COVID-19 produce antibodies that paradoxically shut down their immune system’s virus-fighting response just when they need it most.

Cancer Drug Shows Potent Activity in the Lab Against SARS-CoV-2, Including New Variants

January 25, 2021
In two preclinical models of COVID-19, plitidepsin showed a 100-fold reduction in viral replication in the lungs and demonstrated an ability to reduce lung inflammation.

COVID-19 Variant First Found in Other Countries and States Now Seen More Frequently in California

January 19, 2021
“It’s too soon to know if this variant will spread more rapidly than others," said Erica Pan, MD, MPH, State Epidemiologist for the California Department of Public Health.

Pages